|
Market Closed -
Nasdaq
00:00:00 17/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.27 USD | -6.16% |
|
-17.44% | -37.94% |
| 09-21 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-20 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AVTX | Delayed | |
CBOE
| AVTX | Real-time | |
|
Tradegate
| C6K0 | Real-time | |
|
Deutsche Boerse AG
| C6K0 | Delayed | |
|
Boerse Muenchen
| C6K0 | Real-time | |
|
Börse Stuttgart
| C6K0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 16.07 | 16.07 | 16.57 |
| Spread/Res. | -29.87% | -29.87% | -31.99% |
| Spread/Supp. | +24.94% | +24.94% | +4.35% |
| Support | 9.02 | 9.02 | 10.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
